Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Cerebrospinal Fluid/Plasma Albumin Ratio as a Biomarker for Blood-Brain Barrier Impairment Across Neurodegenerative Dementias

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Mortality in Dementia from 1996 to 2015: A National Registry-Based Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Dickkopf-1 overexpression in vitro nominates candidate blood biomarkers relating to Alzheimer's Disease pathology

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Inflammation in Traumatic Brain Injury

    Research output: Contribution to journalReviewResearchpeer-review

  1. Mortality in Dementia from 1996 to 2015: A National Registry-Based Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Undersøgelse af spinalvæske ved udredning for kognitiv svækkelse og demens

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Perceived stress and dementia: Results from the Copenhagen city heart study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Previous studies have shown an association between disruption of the blood-brain-barrier (BBB) and dementias of different etiologies. The protein concentration of cerebrospinal fluid (CSF) can be used as an indirect measurement for the permeability of the BBB using the CSF/plasma albumin quotient (Q-Alb) or total CSF protein.

OBJECTIVE: In the current study, we wanted to investigate Q-Alb and CSF protein concentration in dementias of different etiologies and the possible confounding factors.

METHODS: A total of 510 patients and healthy controls were included in the current study. The patients were diagnosed with Alzheimer's disease (AD), dementia with Lewy bodies (DLB), vascular dementia (VaD), or frontotemporal dementia (FTD).

RESULTS: We found that Q-Alb was significantly different between the groups (p = 0.002, F = 3.874). Patients with DLB and VaD showed the largest Q-Alb. Although not significant for CSF total protein, we found the same overall pattern for DLB and VaD. When examining confounding factors, we found a positive association with age and a lower Fazekas score in DLB as compared to VaD.

CONCLUSION: These results suggest that Q-Alb can contribute to our understanding of the pathophysiological mechanisms in DLB, and Q-Alb may serve as a supplementary diagnostic marker. Furthermore, we found a positive association with age, which may be due to differences in vascular co-morbidities. In addition, in patients with DLB, the increased Q-Alb is not due to vascular lesions. Studies are needed to validate the possible diagnostic value of Q-Alb in a larger cohort.

Original languageEnglish
JournalJournal of Alzheimer's Disease
Volume75
Issue number2
Pages (from-to)429-436
Number of pages8
ISSN1387-2877
DOIs
Publication statusPublished - May 2020

ID: 61263663